IMTX: Immatics N.V
IMTX exchange rate has changed by -3.83% for today. During the day, the instrument was traded at a low of 9.54 and at a high of 10.13.
Follow Immatics N.V dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
IMTX News
- Immatics (IMTX) Reports Q1 Loss, Lags Revenue Estimates
- ACAD Q1 Earnings & Revenues Miss Estimates Despite Y/Y Sales Growth
- Madrigal Q1 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up
- RXRX Q1 Loss Narrower Than Expected, Revenues Decline Y/Y
- Prime Medicine, Inc. (PRME) Reports Q1 Loss, Misses Revenue Estimates
- All You Need to Know About Immatics (IMTX) Rating Upgrade to Buy
- NVO Q1 Earnings & Sales Top Estimates, 2026 Outlook Raised, Stock Up
- Twist Bioscience (TWST) Reports Q2 Loss, Beats Revenue Estimates
- Immatics: Buying The Anzu-Cel Floor, Playing The Moderna Moonshot (NASDAQ:IMTX)
- Immatics NV earnings beat by €0.13, revenue topped estimates
- Nuvation Bio Inc. (NUVB) Reports Q4 Loss, Beats Revenue Estimates
- Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates
- Immatics Stock: PRAME Leader’s Transition To Commercial Reality (NASDAQ:IMTX)
- Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)
- Salesforce and Micron Tech among market cap stock movers on Friday
- Micron, Salesforce among market cap stock movers on Friday
- Immatics stock price target raised to $17 from $16 at Leerink Partners
- Iovance Biotherapeutics: Several Positives, But Competition Still Threatens (NASDAQ:IOVA)
- Company News for Nov 18, 2025
- Guggenheim raises Immatics stock price target to $19 on positive TCR pipeline data
- Immatics NV earnings missed by €0.04, revenue fell short of estimates
- Immatics stock price target raised to $14 by BofA on PRAME franchise
- Immatics (IMTX) Reports Q3 Loss, Misses Revenue Estimates
- CG Oncology, Inc. (CGON) Reports Q3 Loss, Tops Revenue Estimates
Frequently Asked Questions
What is IMTX stock price today?
Immatics N.V stock is priced at 9.79 today. It trades within 9.54 - 10.13, yesterday's close was 10.18, and trading volume reached 1815. The live price chart of IMTX shows these updates.
Does Immatics N.V stock pay dividends?
Immatics N.V is currently valued at 9.79. Dividend policy depends on the company, while investors also watch -5.41% and USD. View the chart live to track IMTX movements.
How to buy IMTX stock?
You can buy Immatics N.V shares at the current price of 9.79. Orders are usually placed near 9.79 or 10.09, while 1815 and -3.36% show market activity. Follow IMTX updates on the live chart today.
How to invest into IMTX stock?
Investing in Immatics N.V involves considering the yearly range 8.55 - 12.40 and current price 9.79. Many compare -16.75% and -6.85% before placing orders at 9.79 or 10.09. Explore the IMTX price chart live with daily changes.
What are Immatics N.V stock highest prices?
The highest price of Immatics N.V in the past year was 12.40. Within 8.55 - 12.40, the stock fluctuated notably, and comparing with 10.18 helps spot resistance levels. Track Immatics N.V performance using the live chart.
What are Immatics N.V stock lowest prices?
The lowest price of Immatics N.V (IMTX) over the year was 8.55. Comparing it with the current 9.79 and 8.55 - 12.40 shows potential long-term entry points. Watch IMTX moves on the chart live for more details.
When did IMTX stock split?
Immatics N.V has gone through stock splits historically. These changes are visible in , 10.18, and -5.41% after corporate actions.
- Previous Close
- 10.18
- Open
- 10.13
- Bid
- 9.79
- Ask
- 10.09
- Low
- 9.54
- High
- 10.13
- Volume
- 1.815 K
- Daily Change
- -3.83%
- Month Change
- -16.75%
- 6 Months Change
- -6.85%
- Year Change
- -5.41%
- Act
- Fcst
- Prev